SKYCLARYS — Total Revenue
Biogen SKYCLARYS — Total Revenue increased by 13.0% to $150.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.6%, from $123.90M to $150.70M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration, strong physician adoption, and effective commercial execution for this specific rare disease therapy. A decrease may signal increased competition, pricing pressure, or challenges in patient access and reimbursement.
Detailed definition
This metric represents the total gross revenue generated from the sale of the pharmaceutical product SKYCLARYS, a treatm...
Peer comparison
Comparable to revenue metrics for specialized orphan drugs or rare disease therapies at other biopharmaceutical companies, where growth is driven by patient identification and market access.
biib_segment_skyclarys_total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $55.90M | $78.00M | $100.00M | $102.30M | $102.20M | $123.90M | $130.30M | $132.90M | $133.40M | $150.70M |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | — | +39.5% | +28.2% | +2.3% | -0.1% | +21.2% | +5.2% | +2.0% | +0.4% | +13.0% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +82.8% | +58.8% | +30.3% | +29.9% | +30.5% | +21.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's skyclarys — total revenue?
- Biogen (BIIB) reported skyclarys — total revenue of $150.70M in Q1 2026.
- How has Biogen's skyclarys — total revenue changed year-over-year?
- Biogen's skyclarys — total revenue increased by 21.6% year-over-year, from $123.90M to $150.70M.
- What does skyclarys — total revenue mean?
- The total amount of money earned from sales of the drug SKYCLARYS.